1.
Anton E, Blanco J, Egozcue J, Vidal F: Sperm studies in heterozygote inversion carriers: a review. Cytogenet Genome Res 111:297-304 (2005).
2.
Ashley T: G-band position effects on meiotic synapsis and crossing over. Genetics 118:307-317 (1988).
3.
Batanian J, Hulten MA: Electron microscopic investigations of synaptonemal complexes in an infertile human male carrier of a pericentric inversion inv(1)(p32q42). Regular loop formation but defective synapsis including a possible interchromosomal effect. Hum Genet 76:81-89 (1987).
4.
Bhatt S, Moradkhani K, Mrasek K, Puechberty J, Manvelyan M, et al: Breakpoint mapping and complete analysis of meiotic segregation patterns in three men heterozygous for paracentric inversions. Eur J Hum Genet 17:44-50 (2009).
5.
Brown GM, Leversha M, Hulten M, Ferguson-Smith MA, Affara NA, Furlong RA: Genetic analysis of meiotic recombination in humans by use of sperm typing: reduced recombination within a heterozygous paracentric inversion of chromosome 9q32-q34.3 Am J Hum Genet 62:1484-1492 (1998).
6.
Cheng EY, Chen YJ, Disteche CM, Gartler SM: Analysis of a paracentric inversion in human oocytes: nonhomologous pairing in pachytene. Hum Genet 105:191-196 (1999).
7.
Devine DH, Whitman-Elia G, Best RG, Edwards JG: Paternal paracentric inversion of chromosome 2: a possible association with recurrent pregnancy loss and infertility. J Assist Reprod Genet 17:293-296 (2000).
8.
Hultén MA: On the origin of crossover interference: a chromosome oscillatory movement (COM) model. Mol Cytogenet 4:10 (2011).
9.
Kaiser P: Pericentric inversions. Problems and significance for clinical genetics. Hum Genet 68:1-47 (1984).
10.
Kong A, Gudbjartsson DF, Sainz J, Jonsdottir GM, Gudjonsson SA, et al: A high-resolution recombination map of the human genome. Nat Genet 31:241-247 (2002).
11.
Liehr T, Kosayakova N, Schröder J, Ziegler M, Kreskowski K, et al: Evidence for correlation of fragile sites and chromosomal breakpoints in carriers of constitutional balanced chromosomal rearrangements. Balk J Med Genet 14:13-16 (2011).
12.
Malan V, Pipiras E, Sifer C, Kanafani S, Cedrin-Durnerin I, et al: Chromosome segregation in an infertile man carrying a unique pericentric inversion, inv(21)(p12q22.3), analysed using fluorescence in situ hybridization on sperm nuclei: significance for clinical genetics. A case report. Hum Reprod 21:2052-2056 (2006).
13.
Manvelyan M, Schreyer I, Höls-Herpertz I, Köhler S, Niemann R, et al: Forty-eight new cases with infertility due to balanced chromosomal rearrangements: detailed molecular cytogenetic analysis of the 90 involved breakpoints. Int J Mol Med 19:855-864 (2007).
14.
Martin RH: Sperm chromosome analysis in a man heterozygous for a paracentric inversion of chromosome 7 (q11q22). Hum Genet 73:97-100 (1986).
15.
Martin RH: Sperm chromosome analysis in a man heterozygous for a paracentric inversion of chromosome 14 (q24.1q32.1). Am J Hum Genet 64:1480-1484 (1999).
16.
Morel F, Laudier B, Guérif F, Couet ML, Royère D, et al: Meiotic segregation analysis in spermatozoa of pericentric inversion carriers using fluorescence in-situ hybridization. Hum Reprod 22:136-141 (2007).
17.
Vialard F, Delanete A, Clement P, Simon-Bouy B, Aubriot FX, Selva J: Sperm chromosome analysis in two cases of paracentric inversion. Fertil Steril 87:418.e1-5 (2007).
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or...
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.